- Allergy
- Clinical & Experimental Allergy
- Blockade of IL‐4Rα inhibits group 2 innate lymphoid cell responses in asthma patientsAbstract Asthma is a complicated chronic airway inflammatory disorder. In addition to standard steroid treatment, biologic therapies targeting specific cytokines have emerged to reduce exacerbation and improve lung function. Neutralizing antibodies against IL‐5, a critical growth factor for eosinophils, reduced asthma exacerbation in patients with severe eosinophilic asthma.1 Blockade of IL4Rα, the receptor to IL‐4 and IL‐13, also lowered exacer
- ScienceDirect Publication: Annals of Allergy, Asthma & Immunology
- The relationship between latitude and allergic gastroenteritis hospital admissions in New Zealand infantsPublication date: Available online 15 October 2019Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Raymond James Mullins, Dianne E. Campbell, Elizabeth H. Barnes, Carlos A. Camargo
- From the Pages of Allergy Watch: January 2020Publication date: Available online 15 October 2019Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Gerald B. Lee, Vivian Hernandez-Trujillo, Stanley M. Fineman
- Benralizumab Efficacy for Patients with Fixed Airflow Obstruction and Severe, Uncontrolled Eosinophilic AsthmaPublication date: Available online 15 October 2019Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Bradley E. Chipps, Ian Hirsch, Frank Trudo, Marianna Alacqua, James G. Zangrilli
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Πέμπτη 17 Οκτωβρίου 2019
- Allergy
- Clinical & Experimental Allergy
- ScienceDirect Publication: Annals of Allergy, Asthma & Immunology
Αναρτήθηκε από
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
στις
3:25 π.μ.
Ετικέτες
00302841026182,
00306932607174,
alsfakia@gmail.com,
Anapafseos 5 Agios Nikolaos 72100 Crete Greece,
Medicine by Alexandros G. Sfakianakis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου